文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于结肠黏液腺癌阴性淋巴结/T分期比值对数优势比的递归划分分期系统。

Recursive partitioning staging system based on the log odds of the negative lymph node/T stage ratio in colon mucinous adenocarcinoma.

作者信息

Cai Huajun, Zeng Jintao, Wang Ye, Zhuang Jinfu, Liu Xing, Guan Guoxian

机构信息

Department of Colorectal Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

出版信息

Front Immunol. 2024 Dec 20;15:1472620. doi: 10.3389/fimmu.2024.1472620. eCollection 2024.


DOI:10.3389/fimmu.2024.1472620
PMID:39759511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11695370/
Abstract

BACKGROUND: This study aimed to investigate the prognostic significance of the log odds of negative lymph nodes/T stage ratio (LONT) and develop an efficient prognostic staging system using LONT in patients with colon mucinous adenocarcinoma (MAC). METHODS: This study included 5,236 patients diagnosed with colon MAC obtained from the Surveillance, Epidemiology, and End Results database. The Kaplan-Meier method, subgroup analysis, receiver operating characteristic (ROC) curve, and Cox proportional hazard regression model were used to determine the clinical outcomes. Recursive partitioning analysis (RPA) was used to develop a novel prognostic system. RESULTS: The 1-, 3-, and 5-year ROC curves, used to predict cancer-specific survival (CSS) and overall survival (OS), demonstrated that the areas under the ROC curve for LONT were superior to those of pT, pN, and pTNM stages. Additionally, a lower LONT was correlated with worse clinical outcomes. The LONT classification efficiently differentiated the prognosis of patients in terms of OS and CSS. Multivariate Cox analyses revealed that LONT was an independent prognostic factor for both CSS and OS. Based on the pT stage and LONT, a novel prognostic staging system was developed using RPA, demonstrating a good prognostic predictive performance. CONCLUSION: A lower LONT was associated with worse survival in patients with colon MAC. The pT stage and LONT-based prognostic staging system facilitated risk stratification in these patients.

摘要

背景:本研究旨在探讨阴性淋巴结对数/T分期比值(LONT)的预后意义,并开发一种使用LONT的高效预后分期系统,用于结肠黏液腺癌(MAC)患者。 方法:本研究纳入了5236例从监测、流行病学和最终结果数据库中获取的诊断为结肠MAC的患者。采用Kaplan-Meier法、亚组分析、受试者工作特征(ROC)曲线和Cox比例风险回归模型来确定临床结局。采用递归划分分析(RPA)开发一种新的预后系统。 结果:用于预测癌症特异性生存(CSS)和总生存(OS)的1年、3年和5年ROC曲线显示,LONT的ROC曲线下面积优于pT、pN和pTNM分期。此外,较低的LONT与较差的临床结局相关。LONT分类在OS和CSS方面有效地分化了患者的预后。多变量Cox分析显示,LONT是CSS和OS的独立预后因素。基于pT分期和LONT,使用RPA开发了一种新的预后分期系统,显示出良好的预后预测性能。 结论:较低的LONT与结肠MAC患者较差的生存相关。基于pT分期和LONT的预后分期系统有助于对这些患者进行风险分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/cfc9ec1224cd/fimmu-15-1472620-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/3ff19443c925/fimmu-15-1472620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/e5825c54256d/fimmu-15-1472620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/04a17ac35263/fimmu-15-1472620-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/5cc3b71b8842/fimmu-15-1472620-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/b97fe29afac5/fimmu-15-1472620-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/cfc9ec1224cd/fimmu-15-1472620-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/3ff19443c925/fimmu-15-1472620-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/e5825c54256d/fimmu-15-1472620-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/04a17ac35263/fimmu-15-1472620-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/5cc3b71b8842/fimmu-15-1472620-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/b97fe29afac5/fimmu-15-1472620-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e31a/11695370/cfc9ec1224cd/fimmu-15-1472620-g006.jpg

相似文献

[1]
Recursive partitioning staging system based on the log odds of the negative lymph node/T stage ratio in colon mucinous adenocarcinoma.

Front Immunol. 2024-12-20

[2]
Value of the log odds of positive lymph nodes for prognostic assessment of colon mucinous adenocarcinoma: Analysis and external validation.

Cancer Med. 2021-12

[3]
Nomogram based on the log odds of negative lymph node/T stage can predict the prognosis of patients with colorectal cancer: a retrospective study based on SEER database and external validation in China.

BMJ Open. 2024-12-20

[4]
The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients.

J Cancer Res Clin Oncol. 2021-8

[5]
Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.

Front Oncol. 2022-7-19

[6]
Log odds of negative lymph nodes/T stage ratio (LONT): A new prognostic tool for differentiated thyroid cancer without metastases in patients aged 55 and older.

Front Endocrinol (Lausanne). 2023

[7]
Survival Benefits of Postoperative Chemotherapy in Patients With Colorectal Mucinous Adenocarcinoma: An Analysis Utilizing Propensity Score Matching From the Surveillance, Epidemiology, and End Results Database.

Am Surg. 2024-11

[8]
A Prognostic Model Based on the Log Odds Ratio of Positive Lymph Nodes Predicts Prognosis of Patients with Rectal Cancer.

J Gastrointest Cancer. 2024-9

[9]
Prognostic model for log odds of negative lymph node in locally advanced rectal cancer via interpretable machine learning.

Sci Rep. 2025-3-7

[10]
Construction and validation of a novel nomogram based on the log odds of positive lymph nodes to predict cancer-specific survival in elderly patients with gastric adenocarcinoma after radical surgery.

BMC Gastroenterol. 2025-4-2

引用本文的文献

[1]
The microbiome-cancer axis as a hidden contributor to early-onset tumorigenesis.

Med Oncol. 2025-9-6

[2]
Prognostic value of the log odds of negative lymph nodes/T stage ratio (LONT) in postoperative esophageal cancer: a SEER-based study.

Front Oncol. 2025-8-20

本文引用的文献

[1]
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

CA Cancer J Clin. 2024

[2]
Finding the minimum number of retrieved lymph nodes in node-negative colorectal cancer using Real-world Data and the SEER database.

Int J Surg. 2023-12-1

[3]
Optimal examined lymph node number for accurate staging and long-term survival in rectal cancer: a population-based study.

Int J Surg. 2023-8-1

[4]
Colorectal mucinous adenocarcinoma indicates a meaningful subtype: A whole genome sequencing study.

Clin Transl Med. 2023-4

[5]
Log odds of negative lymph nodes/T stage ratio (LONT): A new prognostic tool for differentiated thyroid cancer without metastases in patients aged 55 and older.

Front Endocrinol (Lausanne). 2023

[6]
Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis.

Radiat Oncol. 2023-1-21

[7]
Predictive Value of the Log Odds of Negative Lymph Nodes/T Stage as a Novel Prognostic Factor in Bladder Cancer Patients After Radical Cystectomy.

Front Oncol. 2022-7-19

[8]
Prognostic and Predictive Model of the Log Odds of the Negative Lymph Node/T Stage Ratio in Resectable Gastric Adenocarcinoma Patients.

J Gastrointest Surg. 2022-8

[9]
Establishment and validation of a recursive partitioning analysis based prognostic model for guiding re-radiotherapy in locally recurrent nasopharyngeal carcinoma patients.

Radiother Oncol. 2022-3

[10]
Mucinous adenocarcinoma: A unique clinicopathological subtype in colorectal cancer.

World J Gastrointest Surg. 2021-12-27

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索